نتایج جستجو برای: discontinuation reason

تعداد نتایج: 118143  

Journal: :Clinical and experimental rheumatology 2006
N Ruperto A Ravelli E Castell V Gerloni R Haefner C Malattia F Kanakoudi-Tsakalidou S Nielsen J Bohnsack D Gibbas R Rennebohm O Voygioyka Z Balogh L Lepore E Macejkova N Wulffraat S Oliveira R Russo A Buoncompagni M O Hilário M G Alpigiani M Passo D J Lovell R Merino A Martini E H Giannini

OBJECTIVE To investigate the clinical use patterns, clinical effect and safety of cyclosporine A (CSA) in juvenile idiopathic arthritis (JIA) in the setting of routine clinical care. METHODS An open-ended, phase IV post marketing surveillance study was conducted among members of the Pediatric Rheumatology Collaborative Study Group (PRCSG) and of the Paediatric Rheumatology International Trial...

2017
T. S. Sathyanarayana Rao J Shivanand Manohar Rajesh Raman M. S. Darshan Abhinav Tandon K. N. Karthik N Saraswathi Keya Das G. T. Harsha Swetha Patil Kunkeri Chittaranjan Andrade

BACKGROUND Anxiety and depression are common mental health disorders that are responsible for considerable societal burden. There are no data on cost-efficacy and medication compliance related to the treatment of these disorders in rural India. MATERIALS AND METHODS All consenting adults (n = 455) diagnosed with generalized anxiety or (unipolar) depressive disorders in Suttur village, Karnata...

Journal: :International Journal of Clinical Practice 2007
T N Wise C G Wiltse D V Iosifescu M Sheridan J Y Xu J Raskin

AIM AND METHODS The impact of medical comorbidity on the efficacy and tolerability of duloxetine in elderly patients with major depressive disorder (MDD) was investigated in this study. Data were obtained from a multicentre, randomised, double-blind, placebo-controlled study in 311 patients with MDD aged 65-89. The primary outcome measure was a prespecified composite cognitive score based on fo...

2012
Mitesh J. Borad Kelly K. Curtis Hani M. Babiker Martin Benjamin Raoul Tibes Ramesh K. Ramanathan Karen Wright Amylou C. Dueck Gayle Jameson Daniel D. Von Hoff

UNLABELLED Concomitant medication (CM) use may result in Phase I cancer clinical trial ineligibility due to concern for potential CM-investigational drug interactions or alteration of investigational drug absorption. Few studies have examined the impact of CM use on trial eligibility. METHODS We reviewed records of 274 patients on Phase I trials at a single academic institution. Demographics,...

Journal: :Études écossaises 2008

Journal: :The Auk 1888

Journal: :Journal of the American Medical Association 1911

Journal: :Canadian Review of Sociology/Revue canadienne de sociologie 2017

Journal: :Nature 1910

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید